## EFX: Equifax Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.02 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($201.15)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Equifax Survey Shows Government Caseworkers Optimistic on Efficiency, Identify Automation as a Key Priority for 2026**
- Source: Morningstar | 20251204T130854 | Bullish | Relevance: 100%
- An inaugural Equifax survey reveals that government social service workers are optimistic about efficiency gains, with 100% expecting greater efficiency in the coming year and 57% attributing this to data and technology advancements. While automation is a key priority for expediting aid to applicants, challenges like changing policies, insufficient staffing, and lack of automation persist. The survey highlights the growing importance of data and technology in streamlining tasks and improving service delivery for both caseworkers and beneficiaries.

**2. Greenhouse Funds LLLP Invests $59.94 Million in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251203T101838 | Somewhat-Bullish | Relevance: 100%
- Greenhouse Funds LLLP has made a significant investment in Equifax, acquiring 231,081 shares worth approximately $59.94 million, representing 2.5% of its portfolio. This comes amidst recent insider selling by Equifax executives, while institutional investors like Price T Rowe Associates Inc. MD and Norges Bank have also adjusted their stakes. Equifax reported strong Q3 earnings, beating EPS estimates, raising FY2025 guidance, and declared a quarterly dividend of $0.50.

**3. Here's Why You Should Retain Equifax Stock in Your Portfolio Now**
- Source: www.sharewise.com | 20251205T083732 | Bullish | Relevance: 100%
- Equifax (EFX) is poised for significant growth, with projected revenue increases of 6.50% in 2025 and 8% in 2026, driven by strategic integrations like its AI-driven Optimal Path score planner into Kikoff and the acquisition of Vault Verify to enhance "The Work Number" service. Despite facing rising operating expenses, currently, a Hold-rated stock, Equifax's customer-centric initiatives and advanced AI-powered solutions in risk management and credit reporting are expected to fuel its long-term earnings per share growth. Investors might also consider Byrna Technologies (BYRN) and Veralto Corporation (VLTO), both Buy-rated stocks with strong earnings surprise histories.

**4. Equifax Survey Shows Government Caseworkers Optimistic on Efficiency, Identify Automation as a Key Priority for 2026**
- Source: PR Newswire | 20251204T124736 | Bullish | Relevance: 100%
- An Equifax survey of 500 government social service workers reveals optimism about efficiency, with 100% expecting improvements and 57% attributing this to data and technology advancements in 2026. While challenges like changing policies, insufficient staffing, and lack of automation persist, caseworkers are ready to embrace modernized processes, including universal intake forms and unified caseworker support across programs. The findings highlight the critical role of data and automation in streamlining tasks, improving access to information for verifications, and ultimately enhancing the delivery of aid to applicants.

**5. Equifax Survey Shows Government Caseworkers Optimistic on Efficiency, Identify Automation as a Key Priority for 2026**
- Source: Yahoo Finance | 20251204T000802 | Bullish | Relevance: 100%
- An Equifax study reveals that government social service workers are optimistic about efficiency, with 100% expecting improvements in the coming year, largely driven by data and technology. While 57% anticipate data and automation will boost efficiency by 2026, challenges like changing policies, insufficient staffing, and lack of automation persist. Caseworkers foresee increased complexity from multiple income streams and advocate for streamlined processes like universal intake forms to enhance service delivery.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 13.2% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.02 suggests fair value with growth premium. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.4B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.02 |
| Forward P/E | 24.0 |
| Current P/E | 27.8 |
| YoY Growth | 16.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -1.1% (minimal 5-day change). Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.1%) - potential reversal signal. Below SMA200 (0.87x), long-term trend not supportive. MACD histogram positive (1.25), confirming momentum. RSI neutral at 47. Elevated volume (1.6x 20MA), institutional activity likely. OFD pattern: -DBH (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.15% (CS: 44) | Neutral |
| RSI_14 | 46.9 | Neutral |
| MACD Histogram | 1.25 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 0.955x | Below |
| vs SMA200 | 0.868x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $211.51
- **Stop Loss:** $201.15 (4.9% risk)
- **Target:** $232.23 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 115
- **Position Value:** $24,323.65
- **Portfolio %:** 24.32%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*